[BDRX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[BDRX] Biodexa Pharmaceuticals Plc
Announcement Date
30-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 21.35%
YoY- 21.35%
Quarter Report
BDRX's Result
BDRX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 234 201 84 226 275 237 1,476 -26.42%
PBT -1,699 -1,695 -8,930 -2,626 -3,255 -3,340 -4,785 -15.84%
Tax 169 118 220 416 445 322 683 -20.75%
NP -1,531 -1,577 -8,710 -2,210 -2,810 -3,018 -4,103 -15.14%
Tax Rate - - - - - - - -
Total Cost 1,765 1,778 8,794 2,436 3,085 3,255 5,578 -17.44%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -654.06 -786.53 -10,369.05 -977.65 -1,023.68 -1,276.11 -278.04 15.31%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -124.33 0.00 0.00 0.00 0.00 0.00 0.00 -
EPS Diluted -124.33 0.00 0.00 0.00 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.